Literature DB >> 36258945

Isolated Percutaneous Endoscopic Gastrostomy Site Metastasis From Hypopharyngeal Squamous Cell Carcinoma.

Nicholas D Luke1, Penser Cardenas2, Chad Phillip1, Raji Mohammad3, Ali Raza2.   

Abstract

Head and Neck Squamous Cell Carcinoma (HNSCC) is a relatively uncommon malignancy due to the human papillomavirus or environmental factors such as excessive alcohol or tobacco use. Its most common metastatic locations are the lungs, bone, and liver. We are reporting a much more exceedingly rare site, a percutaneous endoscopic gastrostomy (PEG) site. HNSCC metastases and recurrences are commonly seen; however, they present complex challenges to manage successfully. Our presenting patient had an initial diagnosis of hypopharyngeal squamous cell carcinoma and then developed an isolated metachronous metastatic tumor at the site of his gastrostomy tract approximately one year later.
Copyright © 2022, Luke et al.

Entities:  

Keywords:  chemotherapy; hypopharyngeal carcinoma; metastatic disease; percutaneous endoscopic gastrostomy; surgical resection

Year:  2022        PMID: 36258945      PMCID: PMC9560571          DOI: 10.7759/cureus.29123

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  14 in total

1.  Gastric metastasis of squamous cell carcinoma of the head and neck after percutaneous endoscopic gastrostomy--report of a case.

Authors:  S Preyer; P Thul
Journal:  Endoscopy       Date:  1989-11       Impact factor: 10.093

2.  Metastatic carcinoma to percutaneous endoscopic gastrostomy tube sites. A report of five cases.

Authors:  Lanjing Zhang; Stephanie A Dean; Emma E Furth; Gregory S Weinstein; Virginia A LiVolsi; Kathleen T Montone
Journal:  Am J Clin Pathol       Date:  2014-04       Impact factor: 2.493

3.  Frequency and sites of distant metastases in head and neck squamous cell carcinoma. An analysis of 101 cases at autopsy.

Authors:  P Zbären; W Lehmann
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1987-07

4.  Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.

Authors:  Joris B W Elbers; Abrahim Al-Mamgani; Michiel W M van den Brekel; Katarzyna Jóźwiak; J P de Boer; Peter J F M Lohuis; Stefan M Willems; Marcel Verheij; Charlotte L Zuur
Journal:  Otolaryngol Head Neck Surg       Date:  2018-12-11       Impact factor: 3.497

5.  Ostomy metastasis after pull endoscopic gastrostomy: a unique favorable outcome.

Authors:  Jorge Fonseca; Carla Adriana; Miguel Fróis-Borges; Tânia Meira; Gabriel Oliveira; José Carlos Santos
Journal:  Nutr Hosp       Date:  2015-04-01       Impact factor: 1.057

Review 6.  Current Therapy for Metastatic Head and Neck Cancer: Evidence, Opportunities, and Challenges.

Authors:  Trisha M Wise-Draper; Houda Bahig; Marion Tonneau; Vidhya Karivedu; Barbara Burtness
Journal:  Am Soc Clin Oncol Educ Book       Date:  2022-04

7.  Re-irradiation with concurrent chemotherapy in recurrent head and neck cancer: a decision analysis model based on a systematic review.

Authors:  V Paleri; C G Kelly
Journal:  Clin Otolaryngol       Date:  2008-08       Impact factor: 2.597

Review 8.  Percutaneous endoscopic gastrostomy: indications, technique, complications and management.

Authors:  Ata A Rahnemai-Azar; Amir A Rahnemaiazar; Rozhin Naghshizadian; Amparo Kurtz; Daniel T Farkas
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

Review 9.  Metastatic spread to a percutaneous gastrostomy site from head and neck cancer: case report and literature review.

Authors:  Thomas V Mincheff
Journal:  JSLS       Date:  2005 Oct-Dec       Impact factor: 2.172

Review 10.  Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Big and Intriguing Challenge Which May Be Resolved by Integrated Treatments Combining Locoregional and Systemic Therapies.

Authors:  Franco Ionna; Paolo Bossi; Agostino Guida; Andrea Alberti; Paolo Muto; Giovanni Salzano; Alessandro Ottaiano; Fabio Maglitto; Davide Leopardo; Marco De Felice; Francesco Longo; Salvatore Tafuto; Giuseppina Della Vittoria Scarpati; Francesco Perri
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.